STOCKHOLM, May 8, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that regulatory authorities in Spain in Poland have approved the inclusion of Multiple System ...
Patients typically live about 6 to 10 years after MSA symptoms first appear, with few patients surviving more than 15 years [1],[2]. MSA is significantly debilitating and classified as a rare disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback